Thriving Against the Odds in the Life Sciences Industry
The synergy between the life science/biotech industry and the academic/medical research institutions in the Region cannot be overemphasized. This synergy is vital to the growth of the industry as demonstrated by the success of the Region’s technology parks. In just the past five years...
Click here to read the full Greater Perspective article featuring the Region's Life Sciences Industry.
At the very least, the COVID-19 pandemic has brought tremendous challenges to businesses across Greater Baltimore and around the world. However, even amidst this public health and economic crisis, Greater Baltimore’s innovative start-up ecosystem received over $114 million in total investment...
See the catalyzing investments across Greater Baltimore here.
Founded in 2015 and located in the bwtech@ UMBC Technology Center, FZata, Inc. is an antibody technology company dedicated to developing antibody drugs and oral biotherapeutics. As a University of Maryland Baltimore (UMB) spin-out company, FZata not only has licensed IP from UMB, but...
Learn more in EAGB's July 2020 Industry Spotlight.
In case you missed it, check out the top news stories from across the Region's jurisdictions here.